Mareković I - Search Results

1

Chronic prostatitis caused by Trichomonas vaginalis--diagnosis and treatment.

Skerk V, Schönwald S, Granić J, Krhen I, Barsić B, Mareković I, Roglić S, Desnica B, Zeljko Z. Skerk V, et al. Among authors: marekovic i. J Chemother. 2002 Oct;14(5):537-8. doi: 10.1179/joc.2002.14.5.537. J Chemother. 2002. PMID: 12462437 Clinical Trial. No abstract available.

2

Comparative analysis of azithromycin and clarithromycin efficacy and tolerability in the treatment of chronic prostatitis caused by Chlamydia trachomatis.

Skerk V, Schönwald S, Krhen I, Markovinović L, Barsić B, Mareković I, Roglić S, Zeljko Z, Vince A, Cajić V. Skerk V, et al. Among authors: marekovic i. J Chemother. 2002 Aug;14(4):384-9. doi: 10.1179/joc.2002.14.4.384. J Chemother. 2002. PMID: 12420857 Clinical Trial.

3

Ureaplasma urealyticum and Mycoplasma hominis susceptibility to antimicrobial agents.

Marekovic I, Matesa S, Skerk V, Begovac J, Tambic-Andrasevic A, Skerk V. Marekovic I, et al. J Chemother. 2007 Aug;19(4):465-6. doi: 10.1179/joc.2007.19.4.465. J Chemother. 2007. PMID: 17855195 No abstract available.

4

Comparative randomized pilot study of azithromycin and doxycycline efficacy and tolerability in the treatment of prostate infection caused by Ureaplasma urealyticum.

Skerk V, Mareković I, Markovinović L, Begovac J, Skerk V, Barsić N, Majdak-Gluhinić V. Skerk V, et al. Among authors: marekovic i. Chemotherapy. 2006;52(1):9-11. doi: 10.1159/000090234. Epub 2005 Dec 9. Chemotherapy. 2006. PMID: 16340190 Clinical Trial.

5

Susceptibility of Escherichia coli to nitroxoline, an option for uncomplicated urinary tract infections - the first report from Croatia.

Mareković I, Bošnjak Z, Jurić K, Ćorić M, Popović-Grle S. Mareković I, et al. J Chemother. 2018 May;30(3):189-191. doi: 10.1080/1120009X.2018.1452585. Epub 2018 Mar 20. J Chemother. 2018. PMID: 29557289

6

First Report of NDM-1-Producing Acinetobacter guillouiae.

Bošnjak Z, Plecko V, Budimir A, Mareković I, Bedenić B. Bošnjak Z, et al. Among authors: marekovic i. Chemotherapy. 2014;60(4):250-2. doi: 10.1159/000381256. Epub 2015 Apr 25. Chemotherapy. 2014. PMID: 25925795

7

In vitro susceptibility of carbapenem-resistant Enterobacterales to eravacycline - the first report from Croatia.

Jurić I, Bošnjak Z, Ćorić M, Lešin J, Mareković I. Jurić I, et al. Among authors: marekovic i. J Chemother. 2022 Feb;34(1):67-70. doi: 10.1080/1120009X.2021.1965335. Epub 2021 Aug 17. J Chemother. 2022. PMID: 34402411

8

First report of OXA-48-producing Escherichia coli in Croatia and confirmed intergenic transfer of a plasmid-carrying blaOXA-48 from Klebsiella pneumoniae.

Bošnjak Z, Chlebowicz MA, Mareković I, Rezo Vranješ V, Rossen JW, Budimir A. Bošnjak Z, et al. Among authors: marekovic i. Infect Dis (Lond). 2018 Apr;50(4):313-316. doi: 10.1080/23744235.2017.1395067. Epub 2017 Oct 26. Infect Dis (Lond). 2018. PMID: 29069970 No abstract available.

9

Value of rapid aetiological diagnosis in optimization of antimicrobial treatment in bacterial community acquired pneumonia.

Mareković I, Plecko V, Boras Z, Pavlović L, Budimir A, Bosnjak Z, Puretić H, Zele-Starcević L, Kalenić S. Mareković I, et al. Coll Antropol. 2012 Jun;36(2):401-8. Coll Antropol. 2012. PMID: 22856222

10

Evaluation of Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry in Identification of Nontuberculous Mycobacteria.

Mareković I, Bošnjak Z, Jakopović M, Boras Z, Janković M, Popović-Grle S. Mareković I, et al. Chemotherapy. 2016;61(4):167-70. doi: 10.1159/000442517. Epub 2016 Jan 29. Chemotherapy. 2016. PMID: 26821270

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters